pyrazines has been researched along with AIDS Seroconversion in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goodwin, SR; Laciny, E; Reeds, DN; Royal, M; Struthers, H; Yarasheski, KE | 1 |
1 trial(s) available for pyrazines and AIDS Seroconversion
Article | Year |
---|---|
Dipeptidyl peptidase IV inhibition does not adversely affect immune or virological status in HIV infected men and women: a pilot safety study.
Topics: Adolescent; Adult; Aged; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; HIV Infections; HIV Seropositivity; Humans; Male; Middle Aged; Pilot Projects; Pyrazines; RNA, Viral; Sitagliptin Phosphate; Triazoles | 2013 |